BBVA USA’s Amgen AMGN Stock Holding History

BBVA USA’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.09M	Sell	14,547 -1,281	-8%	-$295K	0.18%	122
2021 Q2	$3.86M	Buy	+15,828	New	+$3.89M	0.22%	102

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BBVA USA's AMGN Position: Q3 2021 in Review

BBVA USA reduced its Amgen (AMGN) stake by 8.1% in Q3 2021, selling an estimated $295K and leaving 14,547 shares worth $3.09M. The position accounts for 0.18% of the portfolio, ranked #122.

BBVA USA first reported a position in AMGN in Q2 2021 and has held it in 2 quarters since. The position peaked at $3.86M in Q2 2021. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

BBVA USA held 14,547 shares of Amgen worth $3.09M as of Q3 2021.
BBVA USA sold 1,281 Amgen shares in Q3 2021, an estimated $295K.
Amgen made up 0.18% of BBVA USA's portfolio in Q3 2021, its #122 holding.
BBVA USA first reported a position in Amgen in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Amgen position peaked at $3.86M in Q2 2021.
2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.